Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors
- PMID: 12234025
- DOI: 10.1080/028418602760169389
Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors
Abstract
Cognitive decline is a significant but largely unrecognized sequela following irradiation for several head and neck tumors, particularly cancer of the nasopharynx and paranasal sinuses. In this article the cellular mechanisms of radiation-induced vascular damage in the temporal lobe and its effects on the medial temporal lobe memory systems are described. Recognition of the mechanisms and site of the injury should permit the use of treatment planning systems, such as 3-dimensional (3-D) conformal and intensity-modulated radiotherapy (IMRT) techniques, to spare large volumes of the temporal lobe from receiving a high dose. Furthermore, the emerging concepts of vascular irradiation damage as an inflammatory fibroproliferative response to endothelial injury may permit the application of measures directed at inhibiting the expression of proinflammatory genes and thus mitigate the inflammatory response. Moreover, comorbid factors such as hypertension, diabetes, lipidemia, obesity and smoking are known to promote atherogenesis and therefore may exacerbate radiation-induced vascular damage. Control of these factors may also reduce the incidence and severity of this sequela.
Similar articles
-
Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):379-84. doi: 10.1016/j.ijrobp.2009.07.1695. Epub 2009 Dec 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20015598
-
Correlating planned radiation dose to the cochlea with primary site and tumor stage in patients with head and neck cancer treated with intensity-modulated radiation therapy.Med Dosim. 2014 Spring;39(1):88-92. doi: 10.1016/j.meddos.2013.10.004. Med Dosim. 2014. PMID: 24485054
-
Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.Semin Oncol. 2002 Dec;29(6 Suppl 19):71-9. doi: 10.1053/sonc.2002.37353. Semin Oncol. 2002. PMID: 12577249
-
Neck irradiation, carotid injury and its consequences.Oral Oncol. 2004 Oct;40(9):872-8. doi: 10.1016/j.oraloncology.2003.12.005. Oral Oncol. 2004. PMID: 15380164 Review.
-
Intensity-modulated radiation therapy for head and neck cancer.Expert Rev Anticancer Ther. 2005 Jun;5(3):515-21. doi: 10.1586/14737140.5.3.515. Expert Rev Anticancer Ther. 2005. PMID: 16001958 Review.
Cited by
-
Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.J Clin Invest. 2009 May;119(5):1124-35. doi: 10.1172/jci34051. J Clin Invest. 2009. PMID: 19425167 Free PMC article.
-
Selective inhibition of microglia-mediated neuroinflammation mitigates radiation-induced cognitive impairment.Radiat Res. 2013 May;179(5):549-56. doi: 10.1667/RR3026.1. Epub 2013 Apr 5. Radiat Res. 2013. PMID: 23560629 Free PMC article.
-
The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders.J Physiol. 2007 May 15;581(Pt 1):7-16. doi: 10.1113/jphysiol.2007.129577. Epub 2007 Mar 8. J Physiol. 2007. PMID: 17347265 Free PMC article. Review.
-
Ionizing Radiation Perturbs Cell Cycle Progression of Neural Precursors in the Subventricular Zone Without Affecting Their Long-Term Self-Renewal.ASN Neuro. 2015 Jun 8;7(3):1759091415578026. doi: 10.1177/1759091415578026. Print 2015 May-Jun. ASN Neuro. 2015. PMID: 26056396 Free PMC article.
-
Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis.J Neurooncol. 2011 Feb;101(3):449-56. doi: 10.1007/s11060-010-0282-x. Epub 2010 Jul 9. J Neurooncol. 2011. PMID: 20617366
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical